21st Century Oncology on roadshow for $400 million eight-year notes

By Paul A. Harris

Portland, Ore., April 21 – 21st Century Oncology, Inc. was scheduled to kick off its $400 million offering of eight-year senior notes (Caa2) with a mid-morning investor conference call on Tuesday, according to an informed source.

A New York lunch was scheduled to get underway at noon ET on Tuesday.

A group breakfast is scheduled for 8 a.m. ET on Wednesday.

The Rule 144A for life deal is scheduled to price on Friday.

Morgan Stanley & Co. LLC, Deutsche Bank Securities Inc., KeyBanc Capital Markets and HSBC Bank are the joint bookrunners.

The notes come with three years of call protection.

The Fort Meyers, Fla.-based provider of cancer treatment services plans to use the proceeds, together with cash on hand and new credit facilities, to repay its existing term loan, to redeem or repurchase its existing notes and for general corporate purposes.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.